NDC 45963-614 – Irinotecan hydrochloride
Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Intravenous
Product NDC45963-614
Product details
- Brand name
- Irinotecan hydrochloride
- Generic name
- Irinotecan hydrochloride
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA078589
- Marketed since
- March 12, 2015
- Marketing end
- September 30, 2027
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Irinotecan Hydrochloride 20 mg/mL
Uses, dosage, side effects and warnings for Irinotecan Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 45963-614-51 | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-51) / 2 mL in 1 VIAL, SINGLE-DOSE | Mar 12, 2015 |
| 45963-614-55 | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614-55) / 5 mL in 1 VIAL, SINGLE-DOSE | Mar 12, 2015 |
Other Irinotecan Hydrochloride products
- 60505-6128 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Apotex Corp.
- 60505-6272 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Apotex Corp.
- 55150-352 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-353 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-354 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-355 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 63323-193 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 61703-349 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Hospira, Inc.
- 67184-0513 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 67184-0512 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 67184-0511 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 25021-230 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Sagent Pharmaceuticals